Ovarian Cancer: Prevention and Its Recurrence

卵巢癌:预防及其复发

基本信息

项目摘要

Following up on our very successful symosium on hormones and ovarian cancer prevention, we propose a series of symposia on prevention. The goal of this symposia series is to understand the genetic and biologic mechanisms involved in ovarian cancer and how these mechanisms can be exploited to devise innovative strategies for the prevention and detection of the disease and its recurrence. It will further address the impact of these modalities on the lives of women and their families. With advances in molecular biology and the emergence of new technologies (e.g., proteomics, genomics), we are gathering remarkable knowledge about the genetic and biologic basis of carcinogenesis. By directly facilitating our understanding of the disease process, this knowledge and technology is suggesting fruitful avenues of primary, secondary and tertiary. This series will bring together leaders in prevention, detection and treatment research in order to exchange their expertise, identify research avenues and form collaborations. The symposia series will be held every other year at the University of Pittsburgh Cancer Institute Herberman Conference Center. The general theme for the series is molecular targets and prevention; each symposium will have a specific theme: immune system, 2005; cell cycle 2006; pharmacogenetics, 2007; hormones 2008; and model systems 2009. The intended audience is basic, clinical and translational researchers in the areas of epidemiology, molecular biology, genetics, cell biology, endocrinology, pathology, gynecologic oncology, and high-throughput technologies, as well as public health researchers and consumer advocates. The specific goals of the workshop include: 1. to further understand the molecular, biologic and genetic mechanisms involved in ovarian cancer that can be targets for prevention; 2. to become familiar with emerging chemoprevention agents and early detection approaches aimed at molecular targets; 3. to learn about new highthroughput technologies; 4. to identify new areas of research based on the molecular mechanisms of the disease;All sessions include 2-3 scientific presentation followed by an open discussion by a leader in the field. A poster session will allow for participation by junior scientists and foster greater exchange of ideas. To date, there have been no other conferences specifically focused on the intersection of ovarian cancer, molecular targets and prevention (other than our 2002 symposium). This series represents a unique opportunity to bring together scientist, policy researchers and consumer advocates to advance the frontier of ovarian cancer research and public health.
继我们非常成功的关于激素和卵巢癌预防的研讨会之后,我们提议举办一系列关于预防的专题讨论会。该系列专题讨论会的目的是了解卵巢癌的遗传和生物学机制,以及如何利用这些机制来制定预防和检测疾病及其复发的创新策略。它将进一步讨论这些方式对妇女及其家庭生活的影响。随着分子生物学的进步和新技术(如蛋白质组学、基因组学)的出现,我们正在收集有关致癌的遗传和生物学基础的重要知识。通过直接促进我们对疾病过程的理解,这种知识和技术提供了丰富的初级、次级和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCESMARY MODUGNO其他文献

FRANCESMARY MODUGNO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCESMARY MODUGNO', 18)}}的其他基金

CEP: Career Enhancement Program
CEP:职业提升计划
  • 批准号:
    10713059
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Core B: TCP: Translational Pathology Core
核心 B:TCP:转化病理学核心
  • 批准号:
    10713055
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes
卵巢癌治疗反应和结果的多组学预测标记
  • 批准号:
    10351697
  • 财政年份:
    2022
  • 资助金额:
    $ 2万
  • 项目类别:
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes
卵巢癌治疗反应和结果的多组学预测标记
  • 批准号:
    10678828
  • 财政年份:
    2022
  • 资助金额:
    $ 2万
  • 项目类别:
NOVEL RISK FACTOR AND POTENTIAL EARLY DETECT MARK OVARIAN CANCER
新的风险因素和潜在的早期检测马克卵巢癌
  • 批准号:
    7201102
  • 财政年份:
    2005
  • 资助金额:
    $ 2万
  • 项目类别:
HORMONE METABOLISM AND BREAST MASSES
激素代谢和乳房质量
  • 批准号:
    7201154
  • 财政年份:
    2005
  • 资助金额:
    $ 2万
  • 项目类别:
Planning Grant for a Study of the Effect of Radiation
辐射影响研究规划拨款
  • 批准号:
    6943252
  • 财政年份:
    2005
  • 资助金额:
    $ 2万
  • 项目类别:
Ovarian Cancer: Prevention and Its Recurrence
卵巢癌:预防及其复发
  • 批准号:
    7124957
  • 财政年份:
    2004
  • 资助金额:
    $ 2万
  • 项目类别:
The Role of Prolactin in Postmenopausal Breast Cancer
催乳素在绝经后乳腺癌中的作用
  • 批准号:
    6948505
  • 财政年份:
    2004
  • 资助金额:
    $ 2万
  • 项目类别:
Hormone Metabolism and Breast Masses
激素代谢和乳房肿块
  • 批准号:
    6974754
  • 财政年份:
    2004
  • 资助金额:
    $ 2万
  • 项目类别:

相似国自然基金

RKTG对ERK信号通路的调控和肿瘤生成的影响
  • 批准号:
    30830037
  • 批准年份:
    2008
  • 资助金额:
    190.0 万元
  • 项目类别:
    重点项目

相似海外基金

Prevention of Radiation-Induced Carcinogenesis by Senolytics
通过 Senolytics 预防辐射诱发的致癌作用
  • 批准号:
    23H03539
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of Prostaglandin D Receptor-mediated Carcinogenesis Mechanism of Colitic Cancer
前列腺素D受体介导的结肠癌致癌机制的阐明
  • 批准号:
    23K08219
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
  • 批准号:
    23K05734
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
  • 批准号:
    478278
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
    Operating Grants
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Mechanism of stringent translation initiation: a probe for its biological relevance
严格翻译起始机制:对其生物学相关性的探索
  • 批准号:
    10660217
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Cytoprotective pathways in esophageal squamous epithelia
食管鳞状上皮的细胞保护途径
  • 批准号:
    10660394
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
NIH resubmission Deyu Li - Etheno adductome and repair pathways
NIH 重新提交 Deyu Li - 乙烯加合组和修复途径
  • 批准号:
    10659931
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Project 2: Ex Vivo Modeling and Analysis of Gastric Precancerous Lesions
项目2:胃癌前病变的离体建模与分析
  • 批准号:
    10715763
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了